Embargo Watch

Keeping an eye on how scientific information embargoes affect news coverage

Archive for July 2017

Five years on, eLife finds the lure of the embargo too strong

with one comment

Five years ago, then-new journal eLife announced that it would eschew embargoes — and my nemesis, the Ingelfinger Rule — in favor of unfettered scientific communication. I applauded the move — which I had some input into — then.

And for more than four years, as best I can tell, the journal stuck to that promise. But not in 2017. Read the rest of this entry »

Written by Ivan Oransky

July 20, 2017 at 9:30 am

Posted in Uncategorized

The American Diabetes Association seems to be confused about what “public” means

leave a comment »

Last month, the American Diabetes Association (ADA) stepped in it a bit.

In a move that predictably richocheted around Twitter — and into the medical trade press — the ADA politely, but publicly, asked attendees of its recent annual meeting to take down photos they’d posted of conference slides. Tweets were fine, as long as they didn’t include pictures of slides.

The policy — a version of “freely available, but embargoed,” drew widespread and deserved criticism. In response, the ADA’s Linda Cann defended the policy, but said it would be reevaluated: Read the rest of this entry »

Written by Ivan Oransky

July 17, 2017 at 9:30 am